1,613
Views
154
CrossRef citations to date
0
Altmetric
Clinical Focus: ADHD, Allergies, and Immunization

Understanding Attention-Deficit/Hyperactivity Disorder from Childhood to Adulthood

, MD & , MD
Pages 97-109 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (14)

Jeff Schein, Lenard A. Adler, Ann Childress, Martin Cloutier, Patrick Gagnon-Sanschagrin, Mikhaïl Davidson, Frédéric Kinkead, Annie Guerin & Patrick Lefebvre. (2022) Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective. Journal of Medical Economics 25:1, pages 193-205.
Read now
Megan K. Galbraith, Christopher E. J. DeWolfe, Sara Bartel, Janine V. Olthuis, Margo C. Watt & Sherry H. Stewart. (2022) Do anxiety sensitivity and impulsivity interact in predicting exercise involvement in emerging adult drinkers and cannabis users?. Cognitive Behaviour Therapy 51:3, pages 243-256.
Read now
Medhat M. Bassiony, Rehab S. Mahdy, Noha Haggag & Ghada Salah Eldeen. (2021) Current attention-deficit/hyperactivity disorder and nonmedical prescription opioid use attributed to tramadol among male adolescents without conduct disorder in Egypt. The American Journal of Drug and Alcohol Abuse 47:5, pages 623-629.
Read now
Tahereh Sadeghiyeh, Seyed Alireza Dastgheib, Mohamad Hosein Lookzadeh, Mahmood Noori-Shadkam, Mohammad Javad Akbarian-Bafghi, Masoud Zare-Shehneh, Zahra Poursharif & Hossein Neamatzadeh. (2020) Association of MTHFR 677C > T and 1298A > C polymorphisms with susceptibility to attention deficit and hyperactivity disorder. Fetal and Pediatric Pathology 39:5, pages 422-429.
Read now
Nannet Buitelaar, Jocelyne Posthumus, Denise Bijlenga, Robert Ferdinand & Jan Buitelaar. (2020) Type and Severity of Intimate Partner Violence in Offenders with and without ADHD. International Journal of Forensic Mental Health 19:2, pages 142-151.
Read now
Gökmen Arslan. (2019) Development and validation of the Youth Externalizing Behavior Screener: A brief and effective measure of behavioral problems. International Journal of School & Educational Psychology 7:sup1, pages 64-74.
Read now
Ann C. Childress, Marina Komolova & F. Randy Sallee. (2019) An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology 15:11, pages 937-974.
Read now
Subhamita Maitra, Mahasweta Chatterjee, Swagata Sinha & Kanchan Mukhopadhyay. (2019) Dopaminergic gene analysis indicates influence of inattention but not IQ in executive dysfunction of Indian ADHD probands. Journal of Neurogenetics 33:4, pages 209-217.
Read now
ChristineT. Sweeney, MarkA. Sembower, MichelleD. Ertischek, Saul Shiffman & SidneyH. Schnoll. (2013) Nonmedical Use of Prescription ADHD Stimulants and Preexisting Patterns of Drug Abuse. Journal of Addictive Diseases 32:1, pages 1-10.
Read now
Jadwiga Najib. (2012) Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder. Adolescent Health, Medicine and Therapeutics 3, pages 51-66.
Read now
Sophie Duong, Kara Chung & Sharon B Wigal. (2012) Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. Expert Opinion on Drug Metabolism & Toxicology 8:5, pages 543-552.
Read now
Timothy E Wilens, Nicholas R Morrison & Jefferson Prince. (2011) An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Review of Neurotherapeutics 11:10, pages 1443-1465.
Read now
Sharon B Wigal & Sophie Duong. (2011) Pharmacokinetic evaluation of eltoprazine. Expert Opinion on Drug Metabolism & Toxicology 7:6, pages 775-781.
Read now

Articles from other publishers (140)

Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker & Mikael H. Sodergren. (2023) UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder. Neuropsychopharmacology Reports.
Crossref
Christopher James Hand. (2023) Neurodiverse undergraduate psychology students' experiences of presentations in education and employment. Journal of Applied Research in Higher Education 15:5, pages 1600-1617.
Crossref
Gulay Cicek & Aydin Akan. (2023) Machine and Deep Learning Based Detection of Attention Deficit Hyperactivity Disorder. Machine and Deep Learning Based Detection of Attention Deficit Hyperactivity Disorder.
Lu Yang, Eva Corpeleijn & Esther Hartman. (2023) A prospective analysis of physical activity and mental health in children: the GECKO Drenthe cohort. International Journal of Behavioral Nutrition and Physical Activity 20:1.
Crossref
Jananheendaran Ragadran, Norazlin Kamal Nor, Juriza Ismail, Jun Jean Ong & Charlotte Sundaraj. (2023) Estimating the Risk of Attention Deficit Hyperactivity Disorder (ADHD) in Parents of Children with ADHD and the Association with Their Children’s Disease Severity and Adherence to Medication. Children 10:9, pages 1440.
Crossref
Deepika Suri, Giulia Zanni, Darshini Mahadevia, Nao Chuhma, Rinki Saha, Stephen Spivack, Nicolò Pini, Gregory S. Stevens, Annette Ziolkowski-Blake, Eleanor H. Simpson, Peter Balsam, Stephen Rayport & Mark S. Ansorge. (2023) Dopamine transporter blockade during adolescence increases adult dopamine function, impulsivity, and aggression. Molecular Psychiatry 28:8, pages 3512-3523.
Crossref
Sophie Gimbach, Daniel Vogel, Roland Fried, Stephen V. Faraone, Tobias Banaschewski, Jan Buitelaar, Manfred Döpfner & Richard Ammer. (2023) The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions. European Neuropsychopharmacology 73, pages 24-35.
Crossref
Elif AKÇAY, Gülsüm AKDENİZ, Pınar ÖZIŞIK & Gulsen YİLMAZ. (2023) Higher Perceived Stress Increases the Subjective Reporting of ADHD: A Sample of Medical StudentsDaha Yüksek Algılanan Stres, DEHB’nin Öznel Bildirimini Artırır: Tıp Fakültesi Öğrencileri Örneklemi. Genel Tıp Dergisi 33:3, pages 261-267.
Crossref
Isabel Morales‐Muñoz, Rachel Upthegrove, Kate Lawrence, Rasiah Thayakaran, Sandra Kooij, Alice M Gregory & Steven Marwaha. (2023) The role of inflammation in the prospective associations between early childhood sleep problems and ADHD at 10 years: findings from a UK birth cohort study . Journal of Child Psychology and Psychiatry 64:6, pages 930-940.
Crossref
Laura Vilar-Ribó, Judit Cabana-Domínguez, Lourdes Martorell, Josep Antoni Ramos-Quiroga, Sandra Sanchez-Roige, Abraham A. Palmer, Elisabet Vilella, Marta Ribasés, Gerard Muntané & María Soler Artigas. (2023) Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan. Neuropsychopharmacology 48:7, pages 981-990.
Crossref
Elisa E. Neuchat, Brooke E. Bocklud, Kali Kingsley, William T. Barham, Patrick M. Luther, Shahab Ahmadzadeh, Sahar Shekoohi, Elyse M. Cornett & Alan D. Kaye. (2023) The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review. Neurology International 15:2, pages 697-707.
Crossref
Goran Trajkovski & Jason Braun. 2023. Designing Context-Rich Learning by Extending Reality. Designing Context-Rich Learning by Extending Reality 1 21 .
Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Sambhu Mondal & Snehasis Jana. (2023) The role of biofield energy treatment on psychological symptoms, mental health disorders, and stress‐related quality of life in adult subjects: A randomized controlled clinical trial. Journal of General and Family Medicine 24:3, pages 154-163.
Crossref
María Rodrigo-Yanguas, Marina Martín-Moratinos, Carlos González-Tardón, Fernando Sanchez-Sanchez, Ana Royuela, Marcos Bella-Fernández & Hilario Blasco-Fontecilla. (2023) Effectiveness of a Personalized, Chess-Based Training Serious Video Game in the Treatment of Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Controlled Trial. JMIR Serious Games 11, pages e39874.
Crossref
Nazar Muhammad, Bhavani G Murugesan, Prakamya Singal, Angelica Antai & Lakshit Jain. (2023) Diagnostic Dilemma of Differentiating Attention-Deficit/Hyperactivity Disorder (ADHD) From Mood Disorders and Other Common Psychiatric Illnesses in Substance Use Patient Population. Cureus.
Crossref
Varinder Kaur, Simon Erridge, Mikael H Sodergren & James J Rucker. (2023) Medical cannabis and attention-deficit hyperactivity disorder. British Journal of Neuroscience Nursing 19:2, pages 65-70.
Crossref
Pantelis Papanastasiou & Athanasios Drigas. (2023) The mediterranean diet, lifestyle factors, dyslexia, ADHD in university students of Greece. Brazilian Journal of Science 2:7, pages 92-102.
Crossref
Stephanie Allen, Stephen K Bradley & Eileen Savage. (2021) Experience and impact of the 1-2-3 magic parent programme for children with ADHD on the family unit from the mothers’ perspectives: A narrative analysis. Journal of Child Health Care 27:1, pages 5-17.
Crossref
Luísa Custódio, Catarina Vizetto‐Duarte, Fatma Cebeci, Beraat Özçelik, Farukh Sharopov, Eda Sönmez Gürer, Manoj Kumar, Marcello Iriti, Javad Sharifi‐Rad & Daniela Calina. (2022) Natural products of relevance in the management of attention deficit hyperactivity disorder. eFood 4:1.
Crossref
Choon Guan Lim, Chui Pin Soh, Shernice Shi Yun Lim, Daniel Shuen Sheng Fung, Cuntai Guan & Tih-Shih Lee. (2023) Home-based brain–computer interface attention training program for attention deficit hyperactivity disorder: a feasibility trial. Child and Adolescent Psychiatry and Mental Health 17:1.
Crossref
Ruixi Piao. 2023. Proceedings of the 2nd International Conference on Humanities, Wisdom Education and Service Management (HWESM 2023). Proceedings of the 2nd International Conference on Humanities, Wisdom Education and Service Management (HWESM 2023) 189 198 .
Nasir Rajah, Richard Mattock & Adam Martin. (2023) How do childhood ADHD symptoms affect labour market outcomes?. Economics & Human Biology 48, pages 101189.
Crossref
Amanda S. Almeida, Fernanda Nunes, Daniela M. Marques, Ana Carolina L. Machado, Catiane B.A. Oliveira & Lisiane O. Porciuncula. (2023) Sex differences in maternal odor preferences and brain levels of GAP-43 and sonic hedgehog proteins in infant SHR and Wistar Kyoto rats. Behavioural Brain Research 436, pages 114102.
Crossref
Devon Johnson, Courtney Clark & Randi Hagerman. 2023. Drug Development in Psychiatry. Drug Development in Psychiatry 225 253 .
Hueng-Chuen Fan, Chuan-Mu Chen, Jeng-Dau Tsai, Kuo-Liang Chiang, Stella Chin-Shaw Tsai, Ching-Ying Huang, Cheng-Li Lin, Chung Y. Hsu & Kuang-Hsi Chang. (2022) Association between Exposure to Particulate Matter Air Pollution during Early Childhood and Risk of Attention-Deficit/Hyperactivity Disorder in Taiwan. International Journal of Environmental Research and Public Health 19:23, pages 16138.
Crossref
Tasmia Hai, Rose Swansburg, Cynthia K. Kahl, Hannah Frank, Kayla Stone, Jean-François Lemay & Frank P. MacMaster. (2022) Right Superior Frontal Gyrus Cortical Thickness in Pediatric ADHD. Journal of Attention Disorders 26:14, pages 1895-1906.
Crossref
Javier Quintero, José R. Gutiérrez-Casares & Cecilio Álamo. (2022) Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review. Neurology and Therapy 11:4, pages 1489-1517.
Crossref
Sarit Alkalay & Orrie Dan. (2022) Effect of short-term methylphenidate on social impairment in children with attention deficit/hyperactivity disorder: systematic review. Child and Adolescent Psychiatry and Mental Health 16:1.
Crossref
Victoria A. Nazarova, Aleksandr V. Sokolov, Vladimir N. Chubarev, Vadim V. Tarasov & Helgi B. Schiöth. (2022) Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Frontiers in Pharmacology 13.
Crossref
Nele Wagener, Wolfgang Lehmann, Kai O. Böker, Eric Röhner & Pietro Di Fazio. (2022) Chondral/Desmal Osteogenesis in 3D Spheroids Sensitized by Psychostimulants. Journal of Clinical Medicine 11:20, pages 6218.
Crossref
Rachel Dum, Aria Ghahramani, Raman Baweja & Alfredo Bellon. (2022) Dopamine Receptor Expression and the Pathogenesis of Attention-Deficit Hyperactivity Disorder: a Scoping Review of the Literature. Current Developmental Disorders Reports 9:4, pages 127-136.
Crossref
Niki Pandria, Vasileia Petronikolou, Aristotelis Lazaridis, Christos Karapiperis, Eleftherios Kouloumpris, Dimitris Spachos, Anestis Fachantidis, Dimitris Vasiliou, Ioannis Vlahavas & Panagiotis Bamidis. (2022) Information System for Symptom Diagnosis and Improvement of Attention Deficit Hyperactivity Disorder: Protocol for a Nonrandomized Controlled Pilot Study. JMIR Research Protocols 11:9, pages e40189.
Crossref
Parina Asgharian, Cristina Quispe, Jesús Herrera-Bravo, Mahsa Sabernavaei, Kamran Hosseini, Haleh Forouhandeh, Tahereh Ebrahimi, Paria Sharafi-Badr, Vahideh Tarhriz, Saiedeh Razi Soofiyani, Paweł Helon, Jovana Rajkovic, Sevgi Durna Daştan, Anca Oana Docea, Javad Sharifi-Rad, Daniela Calina, Wojciech Koch & William C. Cho. (2022) Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update. Frontiers in Pharmacology 13.
Crossref
Parisa Ganjeh, York Hagmayer, Thomas Meyer, Ronny Kuhnert, Ulrike Ravens-Sieberer, Nicole von Steinbuechel, Aribert Rothenberger & Andreas Becker. (2022) Physical activity and the development of general mental health problems or attention-deficit hyperactivity disorder (ADHD) symptoms in children and adolescents: A cross-lagged panel analysis of long-term follow-up epidemiological data. Frontiers in Behavioral Neuroscience 16.
Crossref
Yajing Long, Nanfang Pan, Shiyu Ji, Kun Qin, Ying Chen, Xun Zhang, Min He, Xueling Suo, Yifan Yu, Song Wang & Qiyong Gong. (2022) Distinct brain structural abnormalities in attention-deficit/hyperactivity disorder and substance use disorders: A comparative meta-analysis. Translational Psychiatry 12:1.
Crossref
Chloe Southon. (2022) The relationship between executive function, neurodevelopmental disorder traits, and academic achievement in university students. Frontiers in Psychology 13.
Crossref
Dana Newcomb, Phil Nixon, Perrin Moss & Vishal Kapoor. (2022) Supporting GPs in the Management of Children and Young People with ADHD Through Project ECHO®: Results from a Self-Efficacy Survey. International Journal of Integrated Care 22:3.
Crossref
Yuli Qian & John S. Markowitz. (2022) Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models. Drug Metabolism and Disposition 50:7, pages 968-979.
Crossref
Yilong Wang, Xuebin Xu, Haihua Chen, Mengying Zhu, Xiaotong Guo & Feng Gao. (2022) Micro-RNAs from Plasma-Derived Small Extracellular Vesicles as Potential Biomarkers for Tic Disorders Diagnosis. Brain Sciences 12:7, pages 829.
Crossref
Andrea Mckenzie, Shakila Meshkat, Leanna M.W. Lui, Roger Ho, Joshua D. Di Vincenzo, Felicia Ceban, Bing Cao & Roger S. McIntyre. (2022) The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic review. Journal of Psychiatric Research 149, pages 252-259.
Crossref
Somarani Dash, Yasir Ahmed Syed & Mojibur R. Khan. (2022) Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. Frontiers in Cell and Developmental Biology 10.
Crossref
Beatriz Correia, Joana Fernandes, Maria João Botica, Carla Ferreira & Alexandre Quintas. (2022) Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse. Medicines 9:3, pages 19.
Crossref
Laura Fusar-Poli, Natascia Brondino, Pierluigi Politi & Eugenio Aguglia. (2020) Missed diagnoses and misdiagnoses of adults with autism spectrum disorder. European Archives of Psychiatry and Clinical Neuroscience 272:2, pages 187-198.
Crossref
Himanshu Agrawal. (2021) Never See an Adult Again. Academic Psychiatry 46:1, pages 85-86.
Crossref
Allison S. Baker, Rebecca Wales, Olivia Noe, Peter Gaccione, Marlene P. Freeman & Lee S. Cohen. (2020) The Course of ADHD during Pregnancy. Journal of Attention Disorders 26:2, pages 143-148.
Crossref
Salma N. Younes, Rana Al-Jurf, Sara Hammuda, Gheyath K. Nasrallah, Amal Al-Jurf, Ayah Ziyada, Palli Valapila Abdulrouf, M. Walid Qoronfleh, Muthanna Samara & Nader Al-Dewik. 2022. Proteins Associated with Neurodevelopmental Disorders. Proteins Associated with Neurodevelopmental Disorders 135 189 .
Amber N. Edinoff, Tucker L. Apgar, Jasmine J. Rogers, Joshua D. Harper, Elyse M. Cornett, Adam M. Kaye & Alan D. Kaye. (2021) Attention Deficit Hyperactivity Disorder and Bipolar Disorder: Diagnosis, Treatments, and Clinical Considerations: A Narrative Review. Psychiatry International 3:1, pages 17-28.
Crossref
Xiao Liang, Ru Li, Stephen H. S. Wong, Raymond K. W. Sum & Cindy H. P. Sit. (2021) The impact of exercise interventions concerning executive functions of children and adolescents with attention-deficit/hyperactive disorder: a systematic review and meta-analysis. International Journal of Behavioral Nutrition and Physical Activity 18:1.
Crossref
Luis M. García-Marín, Adrián I. Campos, Gabriel Cuéllar-Partida, Sarah E. Medland, Scott H. Kollins & Miguel E. Rentería. (2021) Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD. Scientific Reports 11:1.
Crossref
Tapotosh Ghosh, Md. Hasan Al Banna, Md. Sazzadur Rahman, M. Shamim Kaiser, Mufti Mahmud, A. S. M. Sanwar Hosen & Gi Hwan Cho. (2021) Artificial intelligence and internet of things in screening and management of autism spectrum disorder. Sustainable Cities and Society 74, pages 103189.
Crossref
Xuan Hau Doan, Trung Thanh Le, Cong Doanh Duong, Thi Phuong Linh Nguyen, Duc Dung Tran & Thi Phuong Hien Tran. (2021) Impulsivity traits and the rational cognitive process of entrepreneurship: empirical evidence from Vietnam. Asia-Pacific Journal of Business Administration 13:4, pages 497-519.
Crossref
Andrea E. Spencer, Jennifer Sikov, J Krystel Loubeau, Nicole Zolli, Tithi Baul, Megan Rabin, Syeda Hasan, Katherine Rosen, Olivia Buonocore, Julia Lejeune, Rohan Dayal, Lisa Fortuna, Christina Borba & Michael Silverstein. (2021) Six Stages of Engagement in ADHD Treatment Described by Diverse, Urban Parents. Pediatrics 148:4.
Crossref
Alexis Janoczkin, Spencer Kiers, Naga Edara, Ping He & Yueling Li. (2021) Impact of COVID-19 pandemic on emergency psychiatry-Millcreek community hospital, Erie, PA. Comprehensive Psychiatry 110, pages 152255.
Crossref
William Das & Shubh Khanna. (2021) A Robust Machine Learning Based Framework for the Automated Detection of ADHD Using Pupillometric Biomarkers and Time Series Analysis. Scientific Reports 11:1.
Crossref
Elena D. Koch, Talar R. Moukhtarian, Caroline Skirrow, Natali Bozhilova, Philip Asherson & Ulrich W. Ebner-Priemer. (2021) Using e-diaries to investigate ADHD – State-of-the-art and the promising feature of just-in-time-adaptive interventions. Neuroscience & Biobehavioral Reviews 127, pages 884-898.
Crossref
Leila Abdool Gafoor, Alban Burke & Jean Fourie. (2021) The efficacy of the Senior South African Individual Scale Revised in distinguishing between attention deficit hyperactivity disorder, normal and sluggish cognitive tempo children. African Journal of Psychological Assessment 3:0.
Crossref
Laura Cutando, Emma Puighermanal, Laia Castell, Pauline Tarot, Federica Bertaso, Patricia Bonnavion, Alban de Kerchove d'Exaerde, Elsa Isingrini, Micaela Galante, Glenn Dallerac, Vincent Pascoli, Christian Lüscher, Bruno Giros & Emmanuel Valjent. (2020) Regulation of GluA1 phosphorylation by d ‐amphetamine and methylphenidate in the cerebellum . Addiction Biology 26:4.
Crossref
Iman Imtiyaz Ahmed Juvale & Ahmad Tarmizi Che Has. (2021) The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders. Journal of Molecular Neuroscience 71:7, pages 1338-1355.
Crossref
Gyeyoon Yim, Andrea Roberts, Alberto Ascherio, David Wypij, Marianthi-Anna Kioumourtzoglou & Marc G. Weisskopf. (2021) Association Between Periconceptional Weight of Maternal Grandmothers and Attention-Deficit/Hyperactivity Disorder in Grandchildren. JAMA Network Open 4:7, pages e2118824.
Crossref
Santosh K. Yadav, Ajaz A. Bhat, Sheema Hashem, Sabah Nisar, Madeeha Kamal, Najeeb Syed, Mohamed-Ramzi Temanni, Rakesh K. Gupta, Saddat Kamran, Muhammad Waqar Azeem, Amit K. Srivastava, Puneet Bagga, Sanjeev Chawla, Ravinder Reddy, Michael P. Frenneaux, Khalid Fakhro & Mohammad Haris. (2021) Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder. Translational Psychiatry 11:1.
Crossref
Gulce Ogruc Ildiz, Ahmet Karadag, Ersin Kaygisiz & Rui Fausto. (2021) PLS-DA Model for the Evaluation of Attention Deficit and Hyperactivity Disorder in Children and Adolescents through Blood Serum FTIR Spectra. Molecules 26:11, pages 3400.
Crossref
Allyson Camp, Amanda Pastrano, Valeria Gomez, Kathleen Stephenson, William Delatte, Brianna Perez, Hunter Syas & Anthony Guiseppi-Elie. (2021) Understanding ADHD: Toward an Innovative Therapeutic Intervention. Bioengineering 8:5, pages 56.
Crossref
Behzad Iravani, Artin Arshamian, Peter Fransson & Neda Kaboodvand. (2021) Whole-brain modelling of resting state fMRI differentiates ADHD subtypes and facilitates stratified neuro-stimulation therapy. NeuroImage 231, pages 117844.
Crossref
Mohammadbagher Hassanzadeh, Ayyoub Malek, Sanaz Norouzi, Shahrokh Amiri, Homayoun Sadeghi-Bazargani, Farshid Shahriari, Helen Link Egger & Brian Small. (2021) Psychometric properties of the Persian version of preschool age psychiatric assessment (PAPA) for attention-deficit/hyperactivity disorder: Based on DSM-5. Asian Journal of Psychiatry 58, pages 102618.
Crossref
Lorenzo Zamboni, Pierpaolo Marchetti, Alessio Congiu, Rosaria Giordano, Francesca Fusina, Silvia Carli, Francesco Centoni, Giuseppe Verlato & Fabio Lugoboni. (2021) ASRS Questionnaire and Tobacco Use: Not Just a Cigarette. A Screening Study in an Italian Young Adult Sample. International Journal of Environmental Research and Public Health 18:6, pages 2920.
Crossref
Kathleen T. Brady, Frances R. Levin, Marc Galanter & Herbert D. KleberTimothy Wilens & Tamar Kaminski. 2021. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment.
Adriana Cojocaru, Lavinia Maria Hogea, Vladimir Poroch, Mihaela Adriana Simu, Virgil Radu Enatescu, Roxana Jeleriu, Nicoleta Ioana Andreescu, Maria Puiu, Bogdan Gheorghe Hogea, Mirela Grigoras, Roxana Folescu, Carmen Lăcrămioara Zamfir, Ileana Enatescu & Laura Alexandra Nussbaum. (2021) Effectiveness of Psychostimulant and Non-Psychostimulant Drug Therapy in the Attention Deficit Hyperactivity Disorder. Applied Sciences 11:2, pages 502.
Crossref
Fahad Alanazi & Yousef Al Turki. (2021) Knowledge and attitude of Attention-Deficit and Hyperactivity Disorder (ADHD) among male primary school teachers, in Riyadh City, Saudi Arabia. Journal of Family Medicine and Primary Care 10:3, pages 1218.
Crossref
Mohd Altaf Paul & Bilal Ahmad Teli. 2021. New Developments in Diagnosing, Assessing, and Treating ADHD. New Developments in Diagnosing, Assessing, and Treating ADHD 220 228 .
Tsuyoshi Imasaka, Jahirul Mullick & Rajesh Jay Sharma. 2021. New Developments in Diagnosing, Assessing, and Treating ADHD. New Developments in Diagnosing, Assessing, and Treating ADHD 146 158 .
Aarzoo Gupta & Archana Kashyap. 2021. New Developments in Diagnosing, Assessing, and Treating ADHD. New Developments in Diagnosing, Assessing, and Treating ADHD 117 131 .
Kaitlyn M.A Parks, Janis E. Oram Cardy, Tiffany G. Woynaroski, Claudia G. Sehl & Ryan A. Stevenson. (2021) Investigating the Role of Inattention and/or Hyperactivity/impulsivity in Language and Social Functioning Using a Dimensional Approach. Journal of Communication Disorders 89, pages 106036.
Crossref
Garima Sharma, Naveen Sharma, Bao Trong Nguyen, Ji Hoon Jeong, Seung-Yeol Nah, Yukio Yoneda, Eun-Joo Shin & Hyoung-Chun Kim. (2020) Protective Potential of Ginkgo biloba Against an ADHD-like Condition. Current Molecular Pharmacology 14:2, pages 200-209.
Crossref
Ingunn Mundal, Rolf W Gråwe, Hege Hafstad, Carlos De las Cuevas & Mariela Loreto Lara-Cabrera. (2020) Effects of a peer co-facilitated educational programme for parents of children with ADHD: a feasibility randomised controlled trial protocol. BMJ Open 10:12, pages e039852.
Crossref
Laura del Hoyo Soriano, Tracie Rosser, Debra Hamilton, Taylor Wood, Leonard Abbeduto & Stephanie Sherman. (2020) Gestational age is related to symptoms of attention-deficit/hyperactivity disorder in late-preterm to full-term children and adolescents with down syndrome. Scientific Reports 10:1.
Crossref
Juan Carlos Corona. (2020) Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder. Antioxidants 9:11, pages 1039.
Crossref
Sara Cooper, Christopher W Hobson & Stephanie HM van Goozen. (2020) Facial emotion recognition in children with externalising behaviours: A systematic review. Clinical Child Psychology and Psychiatry 25:4, pages 1068-1085.
Crossref
T. S. Jaisoorya, K. V. Beena, M. Beena, K. Ellangovan, Sanju George, K. Thennarasu & Shoba Srinath. (2016) Prevalence and Correlates of Self-Reported ADHD Symptoms in Children Attending School in India. Journal of Attention Disorders 24:12, pages 1711-1715.
Crossref
Xaver Berg & Malte Christian Claussen. (2020) ADHS im Leistungssport. DNP - Der Neurologe & Psychiater 21:5, pages 37-42.
Crossref
Arzu Selen, Anette Müllertz, Filippos Kesisoglou, Rodney J. Y. Ho, Jack A. Cook, Paul A. Dickinson & Talia Flanagan. (2020) Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products. The AAPS Journal 22:5.
Crossref
O. Dan. (2020) Recognition of emotional facial expressions in adolescents with attention deficit/hyperactivity disorder. Journal of Adolescence 82:1, pages 1-10.
Crossref
Line M. Holst, Jonas B. Kronborg, Jens R. M. Jepsen, Jette Ø. Christensen, Niels G. Vejlstrup, Klaus Juul, Jesper V. Bjerre, Niels Bilenberg & Hanne B. Ravn. (2020) Attention-deficit/hyperactivity disorder symptoms in children with surgically corrected Ventricular Septal Defect, Transposition of the Great Arteries, and Tetralogy of Fallot. Cardiology in the Young 30:2, pages 180-187.
Crossref
Berit Libutzki, Melanie May, Markus Gleitz, Michael Karus, Benno Neukirch, Catharina A. Hartman & Andreas Reif. (2020) Disease burden and direct medical costs of incident adult ADHD: A retrospective longitudinal analysis based on German statutory health insurance claims data. European Psychiatry 63:1.
Crossref
Franz Moggi, Deborah Schorno, Leila Maria Soravia, Meichun Mohler-Kuo, Natialia Estévez-Lamorte, Joseph Studer & Gerhard Gmel. (2020) Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men. European Addiction Research 26:4-5, pages 233-244.
Crossref
Ekaterina Veniaminova, Margarita Oplatchikova, Lucien Bettendorff, Elena Kotenkova, Alexander Lysko, Ekaterina Vasilevskaya, Allan V. Kalueff, Liliya Fedulova, Aleksei Umriukhin, Klaus-Peter Lesch, Daniel C. Anthony & Tatyana Strekalova. (2020) Prefrontal cortex inflammation and liver pathologies accompany cognitive and motor deficits following Western diet consumption in non-obese female mice. Life Sciences 241, pages 117163.
Crossref
Subhamita Maitra & Kanchan Mukhopadhyay. (2019) Parental age and developmental milestones: pilot study indicated a role in understanding ADHD severity in Indian probands. BMC Pediatrics 19:1.
Crossref
Mark L. Wolraich, Joseph F. HaganJrJr, Carla Allan, Eugenia Chan, Dale Davison, Marian Earls, Steven W. Evans, Susan K. Flinn, Tanya Froehlich, Jennifer Frost, Joseph R. Holbrook, Christoph Ulrich Lehmann, Herschel Robert Lessin, Kymika Okechukwu, Karen L. Pierce, Jonathan D. Winner & William Zurhellen. (2019) Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics 144:4.
Crossref
Sarita A. Dam, Jeanette C. Mostert, Joanna W. Szopinska-Tokov, Mirjam Bloemendaal, Maria Amato & Alejandro Arias-Vasquez. (2019) The Role of the Gut-Brain Axis in Attention-Deficit/Hyperactivity Disorder. Gastroenterology Clinics of North America 48:3, pages 407-431.
Crossref
Mina Aghaei, Hosna Janjani, Fatemeh Yousefian, Akram Jamal & Masud Yunesian. (2019) Association between ambient gaseous and particulate air pollutants and attention deficit hyperactivity disorder (ADHD) in children; a systematic review. Environmental Research 173, pages 135-156.
Crossref
Thomas B. Fay & Martin A. Alpert. (2019) Cardiovascular Effects of Drugs Used to Treat Attention-Deficit/Hyperactivity Disorder. Cardiology in Review 27:3, pages 113-121.
Crossref
A Hamrakova, I Ondrejka, N Sekaninova, L Peregrim & I Tonhajzerova. (2019) Pupillary Light Reflex in Children with ADHD. Acta Medica Martiniana 19:1, pages 30-37.
Crossref
Ahmed Elmarakby, Jessica Faulkner, Paramita Pati, R. Dan Rudic & Clare Bergson. (2019) Increased arterial pressure in mice with overexpression of the ADHD candidate gene calcyon in forebrain. PLOS ONE 14:2, pages e0211903.
Crossref
Paige I. Partain, Jacob White & Paul Hammerness. (2019) New stimulant formulations for pediatric attention-deficit/hyperactivity disorder. Current Opinion in Pediatrics 31:1, pages 166-174.
Crossref
Mathieu Di Miceli, Adesina Omoloye & Benjamin Gronier. (2018) Chronic methylphenidate treatment during adolescence has long-term effects on monoaminergic function. Journal of Psychopharmacology 33:1, pages 109-121.
Crossref
Andreia Azeredo, Diana Moreira & Fernando Barbosa. (2018) ADHD, CD, and ODD: Systematic review of genetic and environmental risk factors. Research in Developmental Disabilities 82, pages 10-19.
Crossref
Andrea E. Spencer, Natalie Plasencia, Ying Sun, Cara Lucke, Haregnesh Haile, Rebecca Cronin, Stephen V. Faraone, Michael Jellinek, J. Michael Murphy & Joseph Biederman. (2018) Screening for Attention-Deficit/Hyperactivity Disorder and Comorbidities in a Diverse, Urban Primary Care Setting. Clinical Pediatrics 57:12, pages 1442-1452.
Crossref
Meital Zur, Racheli Magnezi, Shirley Portuguese, Inbal Reuveni, Ron Kedem & Eyal Fruchter. (2018) The Impact of Adherence to Treatment for ADHD on the Quality of Military Service – The Israeli Military Experience. Military Medicine 183:9-10, pages e518-e524.
Crossref
Andrei A. Puiu, Olga Wudarczyk, Katharina S. Goerlich, Mikhail Votinov, Beate Herpertz-Dahlmann, Bruce Turetsky & Kerstin Konrad. (2018) Impulsive aggression and response inhibition in attention-deficit/hyperactivity disorder and disruptive behavioral disorders: Findings from a systematic review. Neuroscience & Biobehavioral Reviews 90, pages 231-246.
Crossref
Ann ChildressShailly MehrotraJogarao GobburuAngus McLeanNorberto J. DeSousaBev Incledon. (2018) Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 28:1, pages 10-18.
Crossref
Jonita Roman, Devarshi Mehta & Priti Srinivas Sajja. (2017) Learning needs for special needs learners: A graph based adaptive approach for content sequencing. Learning needs for special needs learners: A graph based adaptive approach for content sequencing.
Egon Hagen, Aleksander H. Erga, Sverre M. Nesvåg, James R. McKay, Astri J. Lundervold & Espen Walderhaug. (2017) One-year abstinence improves ADHD symptoms among patients with polysubstance use disorder. Addictive Behaviors Reports 6, pages 96-101.
Crossref
Charlotte Skoglund, Lena Brandt, Brian D’Onofrio, Henrik Larsson & Johan Franck. (2017) Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders. European Neuropsychopharmacology 27:11, pages 1144-1152.
Crossref
Kyriaki Kosidou, Christina Dalman, Linnea Widman, Stefan Arver, Brian K. Lee, Cecilia Magnusson & Renee M. Gardner. (2017) Maternal Polycystic Ovary Syndrome and Risk for Attention-Deficit/Hyperactivity Disorder in the Offspring. Biological Psychiatry 82:9, pages 651-659.
Crossref
Tamás Treuer, Kwok Ling Phyllis Chan, Bung Nyun Kim, Ganesh Kunjithapatham, Dora Wynchank, Bengi Semerci, William Montgomery, Diego Novick & Héctor Dueñas. (2017) Lost in transition: A review of the unmet need of patients with attention deficit/hyperactivity disorder transitioning to adulthood. Asia-Pacific Psychiatry 9:2, pages e12254.
Crossref
Cynthia P. Paidipati, Bridgette Brawner, Ricardo Eiraldi & Janet A. Deatrick. (2017) Parent and Family Processes Related to ADHD Management in Ethnically Diverse Youth. Journal of the American Psychiatric Nurses Association 23:2, pages 90-112.
Crossref
Jadwiga Najib, Dexter WimerJulie ZengKristina W LamNatalya RomanyakEva Paige MorganAnu Thadavila. (2017) Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Central Nervous System Disease 9, pages 117957351772809.
Crossref
Theodore Wasserman & Lori Drucker WassermanTheodore Wasserman & Lori Drucker Wasserman. 2017. Neurocognitive Learning Therapy: Theory and Practice. Neurocognitive Learning Therapy: Theory and Practice 47 53 .
Tanja Vogel, Geert Dom, Geurt van de Glind, Joseph Studer, Gerhard Gmel, Werner Strik & Franz Moggi. (2016) Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss men. Addiction 111:10, pages 1867-1878.
Crossref
Andrea H. Kline-Simon, Constance Weisner & Stacy Sterling. (2016) Point Prevalence of Co-Occurring Behavioral Health Conditions and Associated Chronic Disease Burden Among Adolescents. Journal of the American Academy of Child & Adolescent Psychiatry 55:5, pages 408-414.
Crossref
Nannet J. L. Buitelaar & Robert F. Ferdinand. (2012) ADHD Undetected in Criminal Adults. Journal of Attention Disorders 20:3, pages 270-278.
Crossref
Nicholas Carrellas, Timothy E. Wilens & Rayce Anselmo. (2016) Treatment of Comorbid Substance Use Disorders and ADHD in Youth. Current Treatment Options in Psychiatry 3:1, pages 15-27.
Crossref
Omar Šerý, Ivo Paclt, Ivana Drtílková, Pavel Theiner, Marta Kopečková, Petr Zvolský & Vladimir J. Balcar. (2015) A 40-bp VNTR polymorphism in the 3′-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism. Behavioral and Brain Functions 11:1.
Crossref
Timothy E. Wilens, Brigitte Robertson, Vanja Sikirica, Linda Harper, Joel L. Young, Ralph Bloomfield, Andrew Lyne, Gail Rynkowski & Andrew J. Cutler. (2015) A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry 54:11, pages 916-925.e2.
Crossref
Ganesh Moorthy, Floyd Sallee, Prasad Gabbita, Frank Zemlan, Larry Sallans & Pankaj B. Desai. (2015) Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD. Biopharmaceutics & Drug Disposition 36:7, pages 429-439.
Crossref
Janet K. Kern, David A. Geier, Lisa K. Sykes, Mark R. Geier & Richard C. Deth. (2012) Are ASD and ADHD a Continuum? A Comparison of Pathophysiological Similarities Between the Disorders. Journal of Attention Disorders 19:9, pages 805-827.
Crossref
Hanna Christiansen, Oliver Hirsch, Anika König, Ricarda Steinmayr & Bernd Roehrle. (2015) Prevention of ADHD related problems: a universal preschool program. Health Education 115:3/4, pages 285-300.
Crossref
Charlotte Skoglund, Qi Chen, Johan Franck, Paul Lichtenstein & Henrik Larsson. (2015) Attention-Deficit/Hyperactivity Disorder and Risk for Substance Use Disorders in Relatives. Biological Psychiatry 77:10, pages 880-886.
Crossref
Rémi Radel, Karen Davranche, Marion Fournier & Arne Dietrich. (2015) The role of (dis)inhibition in creativity: Decreased inhibition improves idea generation. Cognition 134, pages 110-120.
Crossref
Jody Mayfield, Yuri A. Blednov & R. Adron Harris. 2015. Structure to Function of G Protein-Gated Inwardly Rectifying (GIRK) Channels. Structure to Function of G Protein-Gated Inwardly Rectifying (GIRK) Channels 279 313 .
J. Russell Ramsay & Anthony L. Rostain. 2015. Attention-Deficit Hyperactivity Disorder in Adults and Children. Attention-Deficit Hyperactivity Disorder in Adults and Children 366 377 .
Timothy E. Wilens & Nicholas R. Morrison. 2015. Attention-Deficit Hyperactivity Disorder in Adults and Children. Attention-Deficit Hyperactivity Disorder in Adults and Children 111 122 .
Erin A. McClure, Susan C. Sonne, Theresa Winhusen, Kathleen M. Carroll, Udi E. Ghitza, Aimee L. McRae-Clark, Abigail G. Matthews, Gaurav Sharma, Paul Van Veldhuisen, Ryan G. Vandrey, Frances R. Levin, Roger D. Weiss, Robert Lindblad, Colleen Allen, Larissa J. Mooney, Louise Haynes, Gregory S. Brigham, Steve Sparenborg, Albert L. Hasson & Kevin M. Gray. (2014) Achieving Cannabis Cessation — Evaluating N-acetylcysteine Treatment (ACCENT): Design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemporary Clinical Trials 39:2, pages 211-223.
Crossref
Courtney A. Zulauf, Susan E. Sprich, Steven A. Safren & Timothy E. Wilens. (2014) The Complicated Relationship Between Attention Deficit/Hyperactivity Disorder and Substance Use Disorders. Current Psychiatry Reports 16:3.
Crossref
Joseph SadekJoseph Sadek. 2014. A Clinician’s Guide to ADHD. A Clinician’s Guide to ADHD 47 62 .
Jose Martinez-Raga, Carlos Knecht, Raquel de Alvaro, Nestor Szerman & Pedro Ruiz. (2013) Addressing Dual Diagnosis Patients Suffering from Attention-Deficit Hyperactivity Disorders and Comorbid Substance Use Disorders. Addictive Disorders & Their Treatment 12:4, pages 213-230.
Crossref
Timothy E. Wilens & Jerrold F. Rosenbaum. (2013) Transitional Aged Youth: A New Frontier in Child and Adolescent Psychiatry. Journal of the American Academy of Child & Adolescent Psychiatry 52:9, pages 887-890.
Crossref
Benno Roesch, Mary E. Corcoran, Jennifer Fetterolf, Mary Haffey, Patrick Martin, Peter Preston, Jaideep Purkayastha, Phillip Wang & James Ermer. (2013) Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate. Drugs in R&D 13:2, pages 119-128.
Crossref
Andrea Seitz, Manuela Wapp, Yuliya Burren, Sonja Stutz, Katrin Schläfli & Franz Moggi. (2013) Association between Craving and Attention Deficit/Hyperactivity Disorder Symptoms among Patients with Alcohol Use Disorders. The American Journal on Addictions 22:3, pages 292-296.
Crossref
. (2013) This Issue: Cases in Adult Attention-Deficit/Hyperactivity Disorder. Psychiatric Annals 43:1, pages 5-8.
Crossref
Gary L. Hedlund. 2013. Evidence-Based Neuroimaging Diagnosis and Treatment. Evidence-Based Neuroimaging Diagnosis and Treatment 299 306 .
Joseph O’Neill, Jennifer G. Levitt & Jeffry R. Alger. 2013. MR Spectroscopy of Pediatric Brain Disorders. MR Spectroscopy of Pediatric Brain Disorders 229 275 .
Yuko Hirata, Clement C. Zai, Behdin Nowrouzi, Joseph H. Beitchman & James L. Kennedy. (2012) Study of the Catechol‐O‐Methyltransferase (COMT) Gene with High Aggression in Children. Aggressive Behavior 39:1, pages 45-51.
Crossref
Nikki Ivanchak, Kristen Fletcher & Gregory A. Jicha. (2012) Attention-Deficit/Hyperactivity Disorder in Older Adults: Prevalence and Possible Connections to Mild Cognitive Impairment. Current Psychiatry Reports 14:5, pages 552-560.
Crossref
Timothy E Wilens & Nicholas R Morrison. (2012) Substance-use disorders in adolescents and adults with ADHD: focus on treatment. Neuropsychiatry 2:4, pages 301-312.
Crossref
Simon Trent, Tommaso Cassano, Gaurav Bedse, Obah A Ojarikre, Trevor Humby & William Davies. (2011) Altered Serotonergic Function may Partially Account for Behavioral Endophenotypes in Steroid Sulfatase-deficient Mice. Neuropsychopharmacology 37:5, pages 1267-1274.
Crossref
Michael G. Kölch, Paul L. Plener & Jörg M. Fegert. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 765 772 .
Timothy E Wilens & Nicholas R Morrison. (2011) The intersection of attention-deficit/hyperactivity disorder and substance abuse. Current Opinion in Psychiatry 24:4, pages 280-285.
Crossref
Chris J. BusheNicola Savill. (2011) Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009-2011. An Update for Clinicians. Journal of Central Nervous System Disease 3, pages JCNSD.S4391.
Crossref
N. Ivanchak, E. L. Abner, S. A. Carr, S. J. Freeman, A. Seybert, J. Ranseen & G. A. Jicha. (2011) Attention-Deficit/Hyperactivity Disorder in Childhood Is Associated with Cognitive Test Profiles in the Geriatric Population but Not with Mild Cognitive Impairment or Alzheimer's Disease. Journal of Aging Research 2011, pages 1-7.
Crossref
Timothy E. Wilens. (2011) A Sobering Fact: ADHD Leads to Substance Abuse. Journal of the American Academy of Child & Adolescent Psychiatry 50:1, pages 6-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.